Roflumilast 500 ug/1

Roflumilast 500 ug/1 is a medication used to manage chronic respiratory conditions. This oral tablet is designed to help improve breathing and reduce inflammation in the lungs.

Roflumilast 500 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by reducing inflammation in the lungs, which can help improve breathing and reduce symptoms such as wheezing and shortness of breath. This medication is often prescribed for long-term management of COPD, helping patients maintain better respiratory function.

Common effects of Roflumilast 500 ug/1 may include headaches, diarrhea, nausea, and weight loss. Some users might also experience insomnia or dizziness. These effects vary from person to person and are not experienced by everyone who takes the medication.

Roflumilast 500 ug/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with a history of mental health conditions should discuss this with their doctor before starting the medication. Always store the tablets in a cool, dry place away from direct sunlight.

Roflumilast 500 ug/1 may interact with certain medications, including those metabolized by the liver's CYP enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional, as it may affect the efficacy of the medication.